Medicare and Medicaid
Our work in Medicare and Medicaid
-
The National Cost of Hospital-Acquired Pressure Injuries in the United States
US Hospital-acquired pressure injury costs could exceed $26.8 billion. HAPIs remain a concern with regard to hospital quality in addition to being a major source of economic burden on the US health care system. Hospitals should invest more in quality improvement of early detection and care for pressure injury to avoid higher costs.
Categorized in -
Reforming Stark/Anti-Kickback Policies
On January 30, U.S. Deputy Secretary of Health and Human Services Eric Hargan will visit Brookings to deliver remarks on reforming Stark/anti-kickback policies. After delivering his prepared remarks there will be a panel discussion including Kimberly Brandt from CMS.
Categorized in -
Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances
The number of physicians excluded from participation in Medicare and state public insurance reimbursement owing to fraud, waste, and abuse increased on average, 20 percent per year, between 2007 and 2017.
Categorized in -
Medicare Graduate Medical Education Funding is Not Addressing the Primary Care Shortage: We Need a Radically Different Approach
Schaeffer Initiative experts evaluate the impact of Medicare funding for hospitals, physicians and medical education on specialty selection by new doctors.
Categorized in -
23nd Annual Wall Street Comes to Washington Healthcare Roundtable
Paul Ginsburg will discuss what the latest market developments mean for national health policy and how federal policies may affect the outlook for healthcare companies with Wall Street analysts.
Categorized in -
CMS Administrator Seema Verma Discusses Prescription for Sustaining US Healthcare System at Schaeffer Initiative Event
CMS Administrator spoke at a USC-Brookings Schaeffer Initiative event in Washington, D.C., to discuss modernizing Medicare and how to protect patients from overpaying for prescription drugs.
Categorized in -
Proposition 3 Could Provide New Resources for Utahns with Diabetes
An overlooked factor in the debate over Proposition 3 is the impact that an expansion of Utah’s Medicaid program would have on the state’s diabetes epidemic, argues Rebecca Myerson in an op-ed in the Salt Lake Tribune.
Categorized in -
Comments on CMS’s Proposed Rule, “Medicare Shared Savings Program; Accountable Care Organizations–Pathways to Success”
Schaeffer fellow Matthew Fiedler submitted a comment letter to Centers the for Medicare and Medicaid Services on proposed rule changes to the Medicare Shared Savings Program. Some proposals may result in cost-savings and greater efficiencies, Fiedler recommends additional analysis in a number of areas.
Categorized in -
Do Price Spikes on Some Generic Drugs Indicate Problems in the Generics Market?
Despite the overall success of the generic drug market, sudden price hikes are becoming more common according to new Schaeffer Center study
Categorized in -
A Conversation with Seema Verma
The USC-Brookings Schaeffer Initiative for Health Policy will host Seema Verma, the Administrator of CMS, for a discussion about Medicare Part D and what can be done to improve the program.
Categorized in